Evidence map›Paper›PMID 39414953›Full record

ArticleCommunications biology2024

Growth stage-related capsular polysaccharide translocon Wza in Vibrio splendidus modifies phage vB_VspM_VS2 susceptibility.

Liming Jiang, Jinsheng Wen, Demeng Tan, Jiasong Xie, Jinquan Li, Chenghua Li

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. From screening to treatment:Microbiology spectrum · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liming Jiang *State Key Laboratory for Quality and Safety of Agroproducts, Ningbo University, Ningbo, China.
Jinsheng Wen *State Key Laboratory for Quality and Safety of Agroproducts, Ningbo University, Ningbo, China.
Demeng TanShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jiasong XieState Key Laboratory for Quality and Safety of Agroproducts, Ningbo University, Ningbo, China.
Jinquan LiCollege of Food Science and Technology, Huazhong Agricultural University, Wuhan, China.
Chenghua LiState Key Laboratory for Quality and Safety of Agroproducts, Ningbo University, Ningbo, China. lichenghua@nbu.edu.cn.ORCID 0000-0003-2978-8762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria at different growth stages usually coordinate capsular polysaccharide (CPS) formation and may affect their susceptibility to phage. In this study, we evaluated the infection efficacy of phage vB_VspM_VS2 in V. splendidus AJ01 at different growth stages and explored the role of growth stage-related CPS translocon Wza in the susceptibility of V. splendidus to phage vB_VspM_VS2. The results showed that V. splendidus locked in the stationary growth stage (SGS) or early exponential stage (EES) infected with phage (EES-P) has a low susceptibility to phage vB_VspM_VS and exhibit a pronounced reduction in phage adsorption rate as compared to the EES bacteria. The expression of wza of CPS transport gene was significantly increased in EES bacteria compared to that bacteria locked in the SGS or EES-P. Bacteria with deleted wza (Δwza mutant) escaped phage adsorption due to absence of Wza mediated down-regulation of CPS expression, otherwise. Our results reveal that the Wza of V. splendidus can promotes phage to infect these bacteria via increasing the phage absorption, which provides important implications for using phages therapeutically target pathogenic bacteria in dynamics communities.

Indexed as

BacteriophagesVibrioBacterial CapsulesBacterial ProteinsPolysaccharides, BacterialBacterial ProteinsPolysaccharides, Bacterial

Identifiers

PMID39414953
PMCPMC11484964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.